TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Glycorex Transplantation AB (publ)
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
2,700
|
3,245
|
2,758 |
| Financial expenses |
35
|
22
|
39 |
| Earnings before taxes |
-2,736
|
-766
|
-1,197 |
| EBITDA |
-806
|
22
|
-327 |
| Total assets |
5,934
|
8,634
|
9,954 |
| Current assets |
2,356
|
4,083
|
4,944 |
| Current liabilities |
1,309
|
1,422
|
1,322 |
| Equity capital |
3,969
|
6,682
|
8,111 |
| - share capital |
333
|
332
|
361 |
| Employees (average) |
23
|
22
|
24 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
66.9%
|
77.4%
|
81.5% |
| Turnover per employee |
117
|
148
|
115 |
| Profit as a percentage of turnover |
-101.3%
|
-23.6%
|
-43.4% |
| Return on assets (ROA) |
-45.5%
|
-8.6%
|
-11.6% |
| Current ratio |
180.0%
|
287.1%
|
374.0% |
| Return on equity (ROE) |
-68.9%
|
-11.5%
|
-14.8% |
| Change turnover |
-555
|
711
|
118 |
| Change turnover % |
-17%
|
28%
|
4% |
| Chg. No. of employees |
1
|
-2
|
2 |
| Chg. No. of employees % |
5%
|
-8%
|
9% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.